Summer 2021 Vol. 11 Issue 02
-
From the Editor-in-Chief
The Tumor MicroenvironmentResearch is leading to treatments that target cancer's support system.
by William G. Nelson, MD, PhD
-
Your Cancer Guide
A Space for Self-CareCancer survivors can build routines to address their needs during and after treatment.
by Hester Hill Schnipper
-
Caregiving With Confidence
Feeling DistantA little bit of planning can help streamline cancer care, even when you are caregiving from afar.
by Karen J. Bannan
-
Policy Matters
COVID-19 Vaccines Are the Key to Restoring Momentum Against CancerCancer screenings and clinical trials have been seriously disrupted by the pandemic.
by Nicholas Warren, PhD
-
A Fast Track for Cancer Vaccines
The rapid development of mRNA COVID-19 vaccines could spark advances in similar treatments for cancer.
by Stephen Ornes
-
Are You a Candidate for Immunotherapy?
Tumor testing can help determine whether certain cancers are likely to respond to immunotherapy drugs.
by Kendall K. Morgan
-
Hope for Cancer Health Equity
Health care providers and communities are making strides toward ensuring equity in cancer treatment.
by Marci A. Landsmann
-
Survivor Profile
Breaking Down BarriersCancer researcher Vicky Forster draws from her own experience with childhood leukemia to emphasize patient voices in cancer research.
by Bradley Jones
-
Q&A
Cancer, From the Other SideWhen Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters.
by Marci A. Landsmann
-
Sound Advice
Your Questions, Our AnswersEnsuring that doctors respect your cultural background, addressing anxiety caused by the pandemic, and discussing end-of-life plans.
-
Get Involved
Bringing Joy to the Pediatric WardStudents Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.
by Bradley Jones
-
Facts and Stats
Categorizing Skin CancerA knowledge of the different types of skin cancer can help you remain vigilant.
by Bradley Jones
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.